Stockscreener 앱 받기
0.795
4.77%
0.0362
전일 마감가:
$0.7588
열려 있는:
$0.7308
하루 거래량:
11.28M
Relative Volume:
0.40
시가총액:
$48.09M
수익:
-
순이익/손실:
$-12.89M
주가수익비율:
-0.3142
EPS:
-2.53
순현금흐름:
$-11.95M
1주 성능:
+35.90%
1개월 성능:
+138.60%
6개월 성능:
-35.70%
1년 성능:
-48.71%
1일 변동 폭
$0.73
$0.867
1주일 범위
$0.5719
$0.90
52주 변동 폭
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
명칭
Plus Therapeutics Inc
전화
737.255.7194
주소
4200 MARATHON BLVD., AUSTIN, TX
PSTV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.795 | 45.96M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-17 | 개시 | D. Boral Capital | Buy |
| 2021-01-25 | 개시 | Ladenburg Thalmann | Buy |
| 2020-10-16 | 개시 | Maxim Group | Buy |
Plus Therapeutics Inc 주식(PSTV)의 최신 뉴스
Arch Therapeutics Inc. (ARTH) Product Pipeline Analysis, 2025 Update - GlobeNewswire Inc.
Plus Therapeutics, Inc. shares rise 2.37% premarket after Almirall and Absci expand AI Drug Creation collaboration. - AInvest
Plus Therapeutics Surges 17.46% on Breakthrough FDA Clearance and Strategic Funding Boost – What’s Next for PSTV? - AInvest
Plus Therapeutics shares rise 3.34% premarket after announcing a dose escalation phase 1 study for 186RNL. - AInvest
How does Plus Therapeutics Inc. generate profit in a changing economyHarness the power of proven investment plans - Jammu Links News
What is the dividend policy of Plus Therapeutics Inc. stockCapitalize on fast-moving stock opportunities - Jammu Links News
What is the risk reward ratio of investing in Plus Therapeutics Inc. stockUnlock real-time stock alerts for quick profits - Jammu Links News
What institutional investors are buying Plus Therapeutics Inc. stockConsistent triple-digit returns - Jammu Links News
What makes Plus Therapeutics Inc. stock price move sharplyFree High-Return Strategy Alerts - Jammu Links News
What analysts say about Plus Therapeutics Inc. stockGet timely advice on market trends - Jammu Links News
What drives Plus Therapeutics Inc. stock priceExtraordinary earning power - Jammu Links News
How strong is Plus Therapeutics Inc. company’s balance sheetTop Growth Trend Scanner With High Returns - jammulinksnews.com
Published on: 2025-08-01 22:18:13 - metal.it
Plus Therapeutics (PSTV.O) Surges 16.5% — What's Behind the Sharp Move? - AInvest
Plus Therapeutics’ Innovative Study on Rhenium-186 NanoLiposome for Cancer Metastases - TipRanks
What are analysts’ price targets for Plus Therapeutics Inc. in the next 12 monthsStock Strategy Recommendation From AI Tools - jammulinksnews.com
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic - GlobeNewswire
Plus Therapeutics (PSTV) to Introduce CNSide Diagnostics in Texas by August 2025 - GuruFocus
Plus Therapeutics Provides US Launch Update for its CNSide® Diag - GuruFocus
Revolutionary CNS Cancer Test With 92% Accuracy Launches at Major Texas Cancer Centers - Stock Titan
Is Plus Therapeutics Inc. stock overvalued or undervaluedReal Time Watchlist With Proven Results - jammulinksnews.com
Plus Therapeutics (PSTV.O) Plunges 13%: Unpacking the Intraday Shock - AInvest
Institutional Tools Highlight Unusual Flow in Plus Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it
Does Plus Therapeutics Inc. stock perform well during market downturnsBuild wealth steadily with proven investment techniques - jammulinksnews.com
Why is Plus Therapeutics Inc. stock attracting strong analyst attentionAmplify your gains with low-risk picks - Jammu Links News
What catalysts could drive Plus Therapeutics Inc. stock higher in 2025Unlock rapid growth potential in your portfolio - jammulinksnews.com
How volatile is Plus Therapeutics Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
Published on: 2025-07-27 20:49:15 - jammulinksnews.com
Healthcare Stocks Move in Intrday Session: Gainers and Losers - AInvest
Should I buy Plus Therapeutics Inc. stock before earningsRecord-setting profit potential - jammulinksnews.com
Can Plus Therapeutics Inc. stock recover from recent declineFree Consultation - Jammu Links News
Plus Therapeutics Inc (PSTV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):